Navitus Earns Sixth PQA Award for High Achievement in Medication Quality Measures
MADISON, Wis., May 17, 2022 – For the sixth year in a row, Navitus Health Solutions, a full pass-through pharmacy benefit manager (PBM), has received the Pharmacy Quality Alliance (PQA) Laura Cranston Excellence in Quality Award for its prescription drug plan (PDP), Navitus MedicareRx. The award was announced during the 2022 PQA Annual Meeting on May 4, 2022.
The 2022 Laura Cranston Excellence in Quality Award recognizes Medicare Advantage Drug Plans (MAPD) and Prescription Drug Plans (PDP) for achieving at least a 4.5-star Part D summary rating and a 5-star rating on all five PQA measures used in the 2022 CMS Star Ratings program. The five PQA measures include Medication Adherence for Diabetes Medications, Medication Adherence for Hypertension (RAS antagonists); Medication Adherence for Cholesterol (Statins); Medication Therapy Management (MTM) Program Completion Rate for Comprehensive Medication Review (CMR); and Statin Use in Persons with Diabetes.
For 2022, Navitus MedicareRx received a 5 out of 5 summary rating, making it Navitus’ sixth year to rank higher than any other PBM-sponsored Medicare PDP Employer Group Waiver Plan. Navitus is one of only twelve healthcare organizations nationwide to receive PQA’s Excellence in Quality Award for PDPs this year. Navitus’ PDP program is managed by Navitus and underwritten by Dean Health Insurance.
“The safe and effective use of medications is a high priority for care providers and the Medicare Part D program,” PQA Chief Executive Officer Micah Cost, PharmD, MS, said. “PQA is proud to recognize 25 plans this year. These awards are a tangible recognition of their commitment to excellence and dedication to providing high-quality care for their Medicare members.”
“Taking medications as prescribed is critical for improving member health outcomes and preventing unnecessary costs. Unfortunately, there are many barriers to adherence, so we are dedicated to improving clinical outcomes through reducing costs, providing personalized support and education to help address these barriers,” said Brent Eberle, senior vice president and chief pharmacy officer at Navitus. “Receiving this award further recognizes Navitus’ commitment to ensuring members receive best-in-class clinical support and customer service.”
The PQA awards are issued annually based on the published CMS Medicare Part D Star Ratings. The awards recognize the nation’s highest achieving prescription drug plans for performance on PQA quality measures of medication safety and appropriate use. The awards reflect PQA’s mission and the vision that co-founder and former CEO Laura Cranston had for building an organization that protects patients and promotes optimal medication outcomes. In 2022, only 2.9% of the 850 Medicare Part D plan contracts qualified for an award.
About Navitus
Navitus Health Solutions, owned by SSM Health and Costco Wholesale Corporation, is a disruptive industry alternative to traditional pharmacy benefit manager (PBM) models. As such, Navitus is committed to taking the unnecessary costs out of pharmacy benefits to make prescriptions more affordable for nearly 1,000 plan sponsors (i.e., employers, health plans, unions, governments, etc.) and their 8.5 million members. By combining a unique pass-through approach that returns 100% of rebates and discounts received, focusing on lowest-net-cost medications and comprehensive clinical care programs, Navitus helps reduce costs and improve member health. To learn more about Navitus, call 877.571.7500 or visit www.navitus.com. Follow Navitus on Twitter and LinkedIn to stay up-to-date on all the latest pharmacy benefit news, information and expert analysis.
For questions and media inquiries, contact [email protected].
Associated People
Stay Informed and Connected
Receive expert insights, healthcare tips, and important updates on pharmacy benefits, drug recalls, and more—straight to your inbox.
Examining Trends that Drive Informed Decisions
Now Available: 8th Annual Drug Trend Report
See the latest results and access industry insights you need to navigate current trend drivers.
Related blogs
Navigating Healthcare and Improving Outcomes
Real-world Data Demonstrates Successful Transitions from Humira to Biosimilars
Authors: Justin Arzt, PharmD; Agata Siwak, PharmD, MSBA; Marnie Wickizer, PharmD, AE-C, CDCES; Ryan Schmidt, PharmD; Robert Topp, RN, PhD; Matt Hustad, PharmD All authors are employees of Navitus Health Solutions. Abstract Adalimumab biosimilar adoption…
PBM 101: Why the Model Matters
In the pharmaceutical and healthcare industry, pharmacy benefit managers (PBMs) are conduits of expertise, analytics and savings opportunities, poised to deliver exceptional health care while driving down costs. They coordinate between drug manufacturers,…
Associate Resource Group Spotlight: Green Team
The Green Team believes that small changes lead to significant impact. Whether its reducing waste, conserving energy or implementing eco-friendly initiatives, they serve as an internal hub for expertise regarding environmental sustainability….
PBM 101: The Three PBM Business Models
In the pharmaceutical and healthcare industry, pharmacy benefit managers (PBMs) are regarded by the media as intermediaries between drug manufacturers, pharmacies, health plans and plan sponsors. But they’re so much more than that. PBMs act as conduits…
An Automated Approach to Diagnosis Verification of GLP-1 RA for Type 2 Diabetes Mellitus (T2DM)
This study examines the impact of implementing an automated point-of-sale diagnosis verification system for glucagon-like peptide-1 receptor agonists (GLP-1 RAs) compared to traditional utilization management approaches….
Navitus to Remove Stelara® from Formulary July 1, 2025, Adds Biosimilars to Drive $120 Million in Savings
As the nation’s first 100% transparent, pass-through PBM, we continue to advance medication affordability by prioritizing upfront, real-time savings over rebated models….
Achieving Outstanding Results with Tailored Network Strategies
A medium-sized city in Michigan with 1,350 members was seeking ways to lower its pharmacy benefit costs, which were growing under its existing traditional pharmacy benefit manager (PBM). With its member covered by a two-tier, open formulary including…
Breaking Through Barriers with Value-Based Plan Design
Facing increased pharmacy benefit expenses, Blain’s Farm and Fleet, a Midwestern employer group, desired to improve plan performance. Specifically it was interested in educating eligible members about the benefits available to them, promoting cost-effective…
Finding a Solution to Lower Prescription Drug Costs
The Rural Arizona Group Health Trust (RAGHT) wanted to gain better control of its escalating drug trend with its large, traditional pharmacy benefit manager (PBM). Having only worked with traditional PBMs in the past, RAGHT was interested in exploring…
